What Is a Useful Strategy for Estimating Survival in Palliative Care Settings for Persons With Advanced Cancer?

Evidence-Based Practice of Palliative Medicine

Volumn , Issue , 2012, Pages 235-240

  Carroll, Thomas ^a   Epstein, Ronald M ^b   Gramling, Robert ^c  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84876273309     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-3796-7.00041-0     Document Type: Chapter

References (24)

1. Downing G.M. "Who Knows?" 10 Steps to Better Prognostication. Palliative Care: Core Skills and Clinical Competencies 2011, 68-78. Saunders, New York. L. Emanuel, L. Librach (Eds.).
2. Lunney J.R., Lynn J., Foley D.J., et al. Patterns of functional decline at the end of life. JAMA. 2003, 289(18):2387-2392.
3. Anderson F., Downing G.M., Hill J., et al. Palliative performance scale (PPS): a new tool. J Palliat Care. 1996, 12(1):5-11.
4. Edge S.B., Byrd D.R., Compton C.C., et al. American Joint Committee on Cancer (AJCC) Cancer Staging Manual 2010, Springer, New York, 261. 7 ed.
5. Non-small Cell Lung Cancer Collaborative Group Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ. 1995, 311(7010):899-909.
6. Woodard T.D., Oplatek A., Petruzzelli G.J. Life after total laryngectomy: a measure of long-term survival, function, and quality of life. Arch Otolaryngol Head Neck Surg. 2007, 133(6):526-532.
7. Duffy S.A., Ronis D.L., McLean S., et al. Pretreatment health behaviors predict survival among patients with head and neck squamous cell carcinoma. J Clin Oncol. 2009, 27(12):1969-1975.
8. Edge S.B., Byrd D.R., Compton C.C., et al. American Joint Committee on Cancer (AJCC) Cancer Staging Manual 2010, Springer, New York, 154. 7 ed.
9. Krzyzanowska M.K., Weeks J.C., Earle C.C. Treatment of locally advanced pancreatic cancer in the real world: population-based practices and effectiveness. J Clin Oncol. 2003, 21(18):3409-3414.
10. Chau I., Norman A.R., Cunningham D., et al. The impact of primary tumour origins in patients with advanced oesophageal, oesophago-gastric junction and gastric adenocarcinoma: individual patient data from 1775 patients in four randomised controlled trials. Ann Oncol. 2009, 20(5):885-891.
11. Dollinger M.M., Lautenschlaeger C., Lesske J., et al. Thymostimulin versus placebo for palliative treatment of locally advanced or metastasised hepatocellular carcinoma: a phase III clinical trial. BMC Cancer. 2010, 10:457.
12. Glimelius B., Ekstrom K., Hoffman K., et al. Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Ann Oncol. 1997, 8(2):163-168.
13. Brown K.M., Tompkins A.J., Yong S., et al. Pancreaticoduodenectomy is curative in the majority of patients with node-negative ampullary cancer. Arch Surg. 2005, 140(6):529-532. discussion 532-523.
14. Motzer R.J., Mazumdar M., Bacik J., et al. Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol. 1999, 17(8):2530-2540.
15. Johnstone P.A., Norton M.S., Riffenburgh R.H. Survival of patients with untreated breast cancer. J Surg Oncol. 2000, 73(4):273-277.
16. Halabi S., Small E.J., Kantoff P.W., et al. Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer. J Clin Oncol. 2003, 21(7):1232-1237.
17. Ohgaki H., Dessen P., Jourde B., et al. Genetic pathways to glioblastoma: a population-based study. Cancer Res. 2004, 64(19):6892-6899.
18. Edge S.B., Byrd D.R., Compton C.C., et al. American Joint Committee on Cancer (AJCC) Cancer Staging Manual 2010, Springer, New York. 7th ed.
19. Edge S.B., Byrd D.R., Compton C.C., et al. American Joint Committee on Cancer (AJCC) Cancer Staging Manual 2010, Springer, New York, 334. 7 ed.
20. Giles F., O'Brien S., Cortes J., et al. Outcome of patients with acute myelogenous leukemia after second salvage therapy. Cancer. 2005, 104(3):547-554.
21. Breems D.A., Van Putten W.L., Huijgens P.C., et al. Prognostic index for adult patients with acute myeloid leukemia in first relapse. J Clin Oncol. 2005, 23(9):1969-1978.
22. Seve P., Ray-Coquard I., Trillet-Lenoir V., et al. Low serum albumin levels and liver metastasis are powerful prognostic markers for survival in patients with carcinomas of unknown primary site. Cancer. 2006, 107(11):2698-2705.
23. Downing M., Lau F., Lesperance M., et al. Meta-analysis of survival prediction with Palliative Performance Scale. J Palliat Care. 2007, 23(4):245-252;. discussion 252-244.
24. Lau F., Downing M., Lesperance M., et al. Using the Palliative Performance Scale to provide meaningful survival estimates. J Pain Symptom Manage. 2009, 38(1):134-144.